DiagnoSTic assays for heparin-induced thrombocytopenia

British Journal of Haematology

Volumn 166, Issue 5, 2014, Pages 631-633

  Gardiner, Elizabeth E ^a   Andrews, Robert K ^a   Cuker, Adam ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heparin induced thrombocytopenia; Thrombocytopenia; Thrombosis

Indexed keywords

HEPARIN; NANOPARTICLE;

CHEMISTRY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PROCEDURES; THROMBOCYTOPENIA;

FEMALE; HEPARIN; HUMANS; IMMUNOASSAY; MALE; NANOPARTICLES; THROMBOCYTOPENIA;

EID: 84905982704     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12940     Document Type: Article

References (12)

1. Arnold, D.M., Nazi, I., Warkentin, T.E., Smith, J.W., Toltl, L.J., George, J.N. & Kelton, J.G. (2013) Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfusion Medicine Reviews, 27, 137-145.
2. Cuker, A. (2014) Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Seminars in thrombosis and hemostasis, 40, 106-114.
3. Cuker, A. & Cines, D.B. (2012) How I treat heparin-induced thrombocytopenia. Blood, 119, 2209-2218.
4. Cuker, A., Arepally, G., Crowther, M.A., Rice, L., Datko, F., Hook, K., Propert, K.J., Kuter, D.J., Ortel, T.L., Konkle, B.A. & Cines, D.B. (2010) The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. Journal of Thrombosis and Haemostasis, 8, 2642-2650.
5. Cuker, A., Rux, A.H., Hinds, J.L., Dela Cruz, M., Yarovoi, S.V., Brown, I.A., Yang, W., Konkle, B.A., Arepally, G.M., Watson, S.P., Cines, D.B. & Sachais, B.S. (2013) Novel diagnostic assays for heparin-induced thrombocytopenia. Blood, 121, 3727-3732.
6. Gardiner, E.E., Karunakaran, D., Arthur, J.F., Mu, F.T., Powell, M.S., Baker, R.I., Hogarth, P.M., Kahn, M.L., Andrews, R.K. & Berndt, M.C. (2008) Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing FcγRIIa. Blood, 111, 165-174.
7. Leroux, D., Hezard, N., Lebreton, A., Bauters, A., Suchon, P., de Maistre, E., Biron, C., Huisse, M., Ternisien, C., Voisin, S., Gruel, Y. & Pouplard, C. (2014) Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert® HIT) for the diagnosis of Heparin-Induced Thrombocytopenia. British Journal of Haematology, doi: 10.1111/bjh.12939.
8. Lo, G.K., Juhl, D., Warkentin, T.E., Sigouin, C.S., Eichler, P. & Greinacher, A. (2006) Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Journal of Thrombosis and Haemostasis, 4, 759-765.
9. Nazi, I., Arnold, D.M., Smith, J.W., Horsewood, P., Moore, J.C., Warkentin, T.E., Crowther, M.A. & Kelton, J.G. (2013) FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis, 11, 1146-1153.
10. Sachs, U.J., von Hesberg, J., Santoso, S., Bein, G. & Bakchoul, T. (2011) Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thrombosis and Haemostasis, 106, 1197-1202.
11. Warkentin, T.E., Greinacher, A., Gruel, Y., Aster, R.H. & Chong, B.H., on behalf of the Scientific and Standardization Committee of The International Society on Thrombosis and Haemostasis (2011) Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. Journal of Thrombosis and Haemostasis, 9, 2498-2500.
12. Watson, H., Davidson, S. & Keeling, D., Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (2012) Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. British Journal of Haematology, 159, 528-540.